¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"vitamin d dependent rickets"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • vitamin K
    ºñŸ¹ÎK
  • antibody-dependent cell-mediated cytotoxicity
    Ç×üÀÇÁ¸¼¼Æ÷¸Å°³¼¼Æ÷µ¶¼º
  • anchorage dependent growth
    ºÎÂøÁõ½Ä, ºÎÂø¹ßÀ°
  • bradycardia dependent bundle branch block
    ´À¸°¸Æ¹ÚÀÇÁ¸´Ù¹ß°¥·¡Â÷´Ü, ¼­¸ÆÀÇÁ¸¼º°¢Â÷´Ü
  • complement-dependent cytotoxicity
    º¸Ã¼ÀÇÁ¸¼¼Æ÷µ¶¼º
  • density dependent inhibition
    ¹ÐµµÀÇÁ¸¾ïÁ¦
  • dependent
    1. ÀÇÁ¸- 2. ÀÇÁ¸¼º 3. Á¾¼ÓÀû
  • dependent drainage
    üÀ§¹è¾×(¹ý)
  • dependent edema
    üÀ§ÀÇÁ¸ºÎÁ¾
  • dependent personality disorder
    ÀÇÁ¸ÀΰÝÀå¾Ö
  • dependent variable
    Á¾¼Óº¯¼ö
  • frequency-dependent
    Á֯ļöÀÇÁ¸Çü
  • hormone dependent
    È£¸£¸óÀÇÁ¸-
  • insulin-dependent
    Àν¶¸°ÀÇÁ¸-
  • insulin-dependent diabetes
    Àν¶¸°ÀÇÁ¸´ç´¢º´
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • thymus-dependent antigen
    °¡½¿»ùÀÇÁ¸Ç׿ø
  • thymus-dependent area
    °¡½¿»ùÀÇÁ¸±¸¿ª
  • bradycardia dependent bundle branch block
    ´À¸°¸Æ¹ÚÀÇÁ¸°¢Â÷´Ü
  • complement-dependent cytotoxicity
    µµ¿òüÀÇÁ¸¼¼Æ÷µ¶¼º
  • thymus-dependent cell
    °¡½¿»ùÀÇÁ¸¼¼Æ÷
  • dependent
    ¾Æ·¡ÂÊ-, ÀÇÁ¸-, ÀÇÁ¸, ÀÇÁ¸¼º
  • density dependent inhibition
    ¹ÐµµÀÇÁ¸¾ïÁ¦
  • dependent edema
    üÀ§ºÎÁ¾
  • dependent strain
    ÀÇÁ¸ÁÖ
  • dependent variable
    Á¾¼Óº¯¼ö
  • dependent personality disorder
    ÀÇÁ¸ÀΰÝÀå¾Ö
  • hormone dependent
    È£¸£¸óÀÇÁ¸
  • hypnotic-dependent disorder
    ¼ö¸éÁ¦ÀÇÁ¸Àå¾Ö, ¼ö¸éÁ¦ÀÇÁ¸º´
  • insulin-dependent diabetes
    Àν¶¸°ÀÇÁ¸´ç´¢º´
  • non-insulin-dependent diabetes
    ºñÀν¶¸°ÀÇÁ¸´ç´¢º´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • DNA-dependent RNA polymerase
    DNA-ÀÇÁ¸ DNA ÁßÇÕÈ¿¼Ò
  • DNA-dependent RNA polymerase
    DNA-ÀÇÁ¸ RNA ÁßÇÕÈ¿¼Ò
  • NADPH-dependent methemoglobin
    NADH-ÀÇÁ¸¸ÞÆ®Çì¸ð±Û·Îºó
  • NADPH-dependent methemoglobin reductase
    NADH-ÀÇÁ¸¸ÞÆ®Çì¸ð±Û·Îºó ¸®´öŸ¾ÆÁ¦
  • NADPH-dependent oxidase system
    NADPH-ÀÇÁ¸¼º »êÈ­È¿¼Ò°è
  • RNA-dependent DNA polymerase
    RNA-ÀÇÁ¸ DNA ÁßÇÕÈ¿¼Ò
  • T dependent antigen
    TÀÇÁ¸¼ºÇ׿ø
  • adcc(antibody dependent cell mediated cytotoxicity)
    Ç×üÀÇÁ¸¼¼Æ÷¸Å°³¼¼Æ÷µ¶¼º(ù÷ô÷ëîðíá¬øàØÚË¿á¬øàÔ¸àõ)
  • antibody dependent cell mediated cytotoxicity
    Ç×üÀÇÁ¸ ¼¼Æ÷¸Å°³ ¼¼Æ÷µ¶¼º.
  • antigen, thymus-dependent
    Èä¼±ÀÇÁ¸Ç׿ø, °¡½¿»ùÀÇÁ¸Ç׿ø
  • area, thymus-dependent
    Èä¼±ÀÇÁ¸¿ª, °¡½¿»ùÀÇÁ¸¿ª
  • frequency dependent
    Á֯ļö ÀÇÁ¸Çü
  • hypersensitivity reactions,type ii(antibody-dependent cell-mediate cyt
    IIÇü
  • hypnotic-dependent disorder
    ¼ö¸éÁ¦ÀÇÁ¸Àå¾Ö, ~º´
  • personality disorder, dependent
    ÀÇÁ¸¼º(ëîðíàõ) ÀΰÝÀå¾Ö
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • renal rickets
    ½Å¼º±¸·çº´
  • renal rickets
    ½Å¼º ±¸·çº´(ãìàõ ץܻ).
  • renal rickets
    ½Å¼º ±¸·çº´(¡­±¸·çÜ»)
  • rickets
    ±¸·çº´(±¸ ׬ܻ).
  • rickets
    ±¸·çº´( ׬ܻ).
  • rickets
    ±¸·çº´(±¸·çÜ»)
  • adcc(antibody dependent cell mediated cytotoxicity)
    Ç×üÀÇÁ¸¼¼Æ÷¸Å°³¼¼Æ÷µ¶¼º(ù÷ô÷ëîðíá¬øàØÚË¿á¬øàÔ¸àõ)
  • anchorage dependent growth
    ºÎÂøÁõ½Ä, ºÎÂø¹ßÀ°
  • antibody dependent cell mediated cytotoxicity
    Ç×üÀÇÁ¸ ¼¼Æ÷¸Å°³ ¼¼Æ÷µ¶¼º.
  • antigen, thymus-dependent
    Èä¼±ÀÇÁ¸Ç׿ø, °¡½¿»ùÀÇÁ¸Ç׿ø
  • area, thymus-dependent
    Èä¼±ÀÇÁ¸¿ª, °¡½¿»ùÀÇÁ¸¿ª
  • bradycardia dependent bundle branch block
    ¼­¸ÆÀÇÁ¸¼º °¢Â÷´Ü(ßïØæëîðíàõ ÊÅó´Ó¨).
  • bradycardia dependent bundle branch block
    ¼­¸ÆÀÇÁ¸¼º °¢Â÷´Ü.
  • cell, thymus-dependent
    °¡½¿»ùÀÇÁ¸¼¼Æ÷, Èä¼±ÀÇÁ¸¼¼Æ÷
  • complement dependent cytotoxicity
    º¸Ã¼ÀÇÁ¸¼º ¼¼Æ÷µ¶¼º
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • antihemorrhagic vitamin
    Ç×ÃâÇ÷¼º(ù÷õóúìàõ)ºñŸ¹Î
  • antirachitic vitamin
    Ç×±¸·çº´(ù÷±¸·çÜ») ºñŸ¹Î
  • B vitamin
    B-ºñŸ¹Î
  • conditioned vitamin deficiency
    Á¶°ÇºÎ(ðÉËìݾ) ºñŸ¹Î°áÇË(ÌÀù¹)
  • fast-soluble vitamin
    Áö¿ë¼º(ò·éÁàõ) ºñŸ¹Î
  • fertility vitamin
    ¼öÁ¤(áôïñ) ºñŸ¹Î
  • koagulations vitamin
    ÀÀ°í(ëêͳ)ºñŸ¹Î
  • lipid-soluble vitamin
    Áö¿ë¼º(ò·éÁàõ)ºñŸ¹Î
  • vitamin
    ºñŸ¹Î
  • vitamin A
    ºñŸ¹Î A
  • vitamin A1
    ºñŸ¹Î A1
  • vitamin A2
    ºñŸ¹Î A2
  • vitamin A1 acid
    ºñŸ¹Î A1 »ê(ß«)
  • vitamin A1 alcohol
    ºñŸ¹Î A1 ¾ËÄÚȦ
  • vitamin A1 aldehyde
    ºñŸ¹Î A1 ¾Ëµ¥ÇÏÀ̵å
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
TD tabes dorsalis; tardive dyskinesia; T-cell dependent; temporary disability; terminal device; tetanus...
FHR familial hypophosphatemic rickets; fetal heart rate
HHRH hereditary hypophosphatemic rickets with hypercalciuria; hypothalamic hypophysiotropic releasing hor...
HPDR hypophosphatemic D-resistant rickets
HR heart rate; hemorrhagic retinopathy; high resolution; higher rate; histamine receptor; hormonal resp...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
VD3 1,25-dihydroxy-Vitamin D3
VDR 1,25-dihydroxy-vitamin D3 receptor
VDR D/vitamin D receptor
hVDR Human vitamin D receptor
PIVKA-II Protein induced by vitamin K absence or antagonist II
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • serum vitamin B12
    Ç÷û ºñŸ¹Î B12
  • vitamin A
    ºñŸ¹Î A
  • vitamin B 21
    ºñŸ¹ÎB 21
  • vitamin B complex
    ºñŸ¹ÎB º¹ÇÕü
  • vitamin B12
    ºñŸ¹Î B12
    ½Ã¾Æ³ëÄڹ߶ó¹Î. Ç׺óÇ÷ ÀÎÀڷμ­ Àû»ö °áÁ¤. 4°³ÀÇ ÇÇ·Ñ ÇÙÀÇ 3°³ÀÇ Åº¼Ò ¿øÀÚ¿Í 6°³ÀÇ °ø¿ª ÀÌÁß °áÇÕÀ» Áö´Ñ ȯ»ó ±¸Á¶¸¦ ÀÌ·ç¸ç ÄÚ¹ßÆ®¸¦ Áö´Ñ´Ù. ½Ã¾È±â°¡ ÄÚ¹ßÆ®¿¡ ¹èÀ§°áÇÕÇØ ÀÖ´Ù. ºñŸ¹Î B12´Â ¼ö¿ë¼ºÀÌ¸ç ¾ËÄڿÿ¡ ¿ëÇØÇÏÁö¸¸ ¾Æ¼¼Åæ, ¿¡Å׸£¿¡´Â ³ìÁö ¾Ê´Â´Ù. »ê¿¡ ¾ÈÁ¤, ¾ËÄ®¸®¿¡´Â ºÒ¾ÈÁ¤ÇÏ´Ù. Co¿øÀÚ¿¡ °áÇÕÇÑ ½Ã¾È±â ´ë½Å¿¡ OH±â¶ó¸é ÇÏÀ̵å·Î¿Á½Ã Äڹ߶ó¹Î, CH3±â¶ó¸é ¸ÞÆ¿ Äڹ߶ó¹ÎÀ̶ó°í ÇÑ´Ù. ½Ã¾Æ³ë Äڹ߶ó¹Î ¼ö¿ë¾×Àº 278nm, 361nm, 548nm¿¡¼­ ÃÖ´ëÇÑ Èí¼öµÈ´Ù. ÀÌ ºñŸ¹ÎÀº Á¶Ç÷ ±â±¸¿¡ Áß¿äÇϸç, RNA¿¡¼­ DNAÀÇ Çü¼º ¹ÝÀÀ¿¡ °ü¿©ÇÑ´Ù°í »ý°¢µÈ´Ù. ½Ä»çÁßÀÇ ºñŸ¹Î B12´Â ¼ÒÀå Á¾¸»ºÎ¿¡¼­ Ä®½·, À§º®¿¡¼­ »ý»êµÇ´Â ³»ÀÎÀÚ ¹«ÄڴܹéÀÇ Á¸Àç ¾Æ·¡ Èí¼öµÈ´Ù. Ç÷û ¹Ý°¨±â´Â ¾à 1ÁÖÀÏÀÌ´Ù.
  • vitamin B12-intrinsic factor
    ºñŸ¹Î B12-³»Àμº ÀÎÀÚ
  • vitamin B2 deficiency
    ºñŸ¹Î B2 °áÇÌÁõ
  • vitamin C
    ºñŸ¹Î C
    ¾Æ½ºÄݺó»ê. Ç×±«Ç÷Áõ ÀÛ¿ëÀ» ÇÑ´Ù. ¿­¿¡ ¾àÇÏ°í °­·ÂÇÑ È¯¿ø ÀÛ¿ëÀÌ ÀÖ¾î, ¿©·¯ È¿¼ÒÀÇ ÀÛ¿ë ¹ßÇö¿¡ ÀÖ¾î Àû´çÇÑ »êȭȯ¿ø »óÅÂÀÇ À¯Áö¿¡ µµ¿òÀÌ µÇ¸ç, ¼ö¼Ò¿î¹Ýü·Î¼­ ÀÛ¿ëÇϰí ÀÖ´Ù. »êÈ­´Â ºû, ¾ËÄ®¸®, ö, ±¸¸®¿¡ ÀÇÇÏ¿© ÃËÁøµÈ´Ù. ½ºÅ×·ÎÀÌµå »ýÇÕ¼º ¶§ÀÇ ¼ö»êÈ­¿¡µµ ¾Æ½ºÄÚ¸£ºó »êÀÌ °ü¿©ÇÑ´Ù.
  • vitamin compound
    ºñŸ¹Î º¹ÇÕÁ¦
    ºñŸ¹ÎÀ» ÁÖ¼ººÐÀ¸·Î ÇÏ´Â ¿µ¾çÁ¦·Î¼­ ºñŸ¹Î °áÇÌÁõÀÇ Ä¡·á¿Í ¿¹¹æ¿¡ »ç¿ëµÇ´Â ÀǾàǰ. ÇöÀç ºñŸ¹Î B2¸¦ Á¦¿ÜÇÑ ´ëºÎºÐÀÇ ºñŸ¹ÎµéÀº ÇÕ¼ºÇÒ ¼ö ÀÖ°í È­Çлê¾÷¿¡ ÀÇÇØ ´Ù·®À¸·Î Á¦Á¶°¡ °¡´ÉÇϹǷΠ´ëºÎºÐÀÇ ºñŸ¹ÎÁ¦´Â ÇÕ¼ºÇ°À¸·Î ¸¸µé¾îÁø´Ù. ´ÜÀÏ Á¦Á¦ Áß¿¡ ÇÑ Á¾·ùÀÇ ºñŸ¹ÎÀ» Æ÷ÇÔÇϵµ·Ï ¸¸µç ´ÜÀÏ ºñŸ¹ÎÁ¦, Áö¿ë¼º ÈæÀº ¼ö¿ë¼º ºñŸ¹Î ¸î Á¾·ù¸¸À» º¹ÇÕ½ÃÄÑ ¸¸µç º¹ÇÕ ºñŸ¹ÎÁ¦, °ÅÀÇ ¸ðµç ºñŸ¹ÎÀ» Æ÷ÇÔÇϵµ·Ï ¸¸µç Á¾ÇÕ ºñŸ¹ÎÁ¦°¡ ÀÖ¾î ¿ëµµ¿¡ µû¶ó »ç¿ëµÈ´Ù. ºñŸ¹ÎÁ¦´Â Áúº´, ¾Ë·¹¸£±â, ½Ä»çÀÇ Á¦ÇÑ µî ¾î¶² ÀÌÀ¯¿¡¼­ ÀûÀýÇÑ ½Ä»ç¸¦ ÇÏÁö ¸øÇÏ´Â »ç¶÷¿¡°Ô´Â ¸Å¿ì À¯¿ëÇϳª Á¤±Ô½Ä»ç¸¦ ÇÏ´Â °Ç°­ÇÑ »ç¶÷ÀÌ ºñŸ¹ÎÀ» ´õ º¸Ãæ¼·ÃëÇϱâ À§ÇÏ¿© »ç¿ëÇÏ´Â °ÍÀº ³¶ºñÀ̰ųª ÇØ°¡ µÇ´Â °æ¿ìµµ ÀÖÀ¸¹Ç·Î »ï°¡¾ß ÇÑ´Ù. 5°¡Áö ±âÃʽÄǰ±º¿¡ ±âº»À» µÐ ±ÕÇü½Ä»ç´Â ¸öÀÌ ÇÊ¿ä·Î ÇÏ´Â ¸ðµç ºñŸ¹ÎÀ» °ø±ÞÇϱ⿡ ÃæºÐÇϸç, Çʿ䷮ ÀÌ»óÀÇ ºñŸ¹ÎÀÌ °Ç°­¿¡ ÇØ·Ó±â ¶§¹®ÀÌ´Ù. Á¤±Ô½Ä»ç¸¦ ÅëÇÑ ºñŸ¹ÎÀÇ ¼·Ãë´Â °áÄÚ °úÀ× µ¶¼º¼öÁرîÁö °¡Áö ¾ÊÁö¸¸, ³óÃàµÈ ºñŸ¹ÎÁ¦¸¦ °è¼Ó ¸ÔÀ¸¸é °úÀ× µ¶¼º ¼öÁرîÁö À̸£°Ô µÈ´Ù. ½Ä»ç¸¦ ÅëÇÏ¿© °Ç°­À¯Áö¿Í Áúº´¿¹¹æ¿¡ ÇÊ¿äÇÑ ¸ðµç ºñŸ¹ÎÀ» ¼·ÃëÇØ¾ß ÇÑ´Ù.
  • vitamin D
    ºñŸ¹ÎD
    ºñŸ¹ÎÀÇ ÇѰ¡Áö. Ç÷¾× ¼ÓÀÇ Ä®½·À» Á¶ÀýÇÏ¸ç °áÇÌµÇ¸é ±¸·çº´ÀÌ µÊ. °£À¯, ´Þ°¿ ³ë¸¥ÀÚ µûÀ§¿¡ µé¾î ÀÖÀ½.
  • vitamin D deficiency
    ºñŸ¹Î D °áÇÌ, ºñŸ¹Î D °áÇÌÁõ
    ±¸·çº´-°ñ¿¬È­ÁõÀ¸·Î µî»À³ª °¡½¿»À µûÀ§°¡ ±Á´Â º´. °ö»çº´.
  • vitamin D dependency
    ºñŸ¹Î D ÀÇÁ¸¼º
  • vitamin D milk
    ºñŸ¹ÎD ¿ìÀ¯
  • vitamin D resistant osteomalacia
    ºñŸ¹ÎD ÀúÇ×¼º °ñ¿¬È­, ºñŸ¹ÎD ÀúÇ×¼º °ñ¿¬È­Áõ
  • vitamin deficiency
    ºñŸ¹Î °áÇÌ, ºñŸ¹Î °áÇÌÁõ
    ¸é Á¾·ùÀÇ ½ÄǰÀ» ¼¯Àº º¸ÅëÀÇ ½Ä»ç¸¦ º¸Åë Á¶¸®¹ý¿¡ µû¶ó ¸ÔÀ» °æ¿ì´Â ºñŸ¹Î °áÇÌÁõÀÌ ³ªÅ¸³ªÁö ¾Ê´Â´Ù. ±×·¯³ª ¿¹¿Ü·Î½á ºñŸ¹Î D°áÇÌÁõÀº ÀÚÁÖ ³ªÅ¸³­´Ù. ½Äǰ Áß¿¡´Â ¿©·¯ Á¾·ùÀÇ ºñŸ¹ÎÀÌ °øÁ¸Çϰí Àֱ⠶§¹®¿¡ 1 Á¾·ù¸¸ÀÇ ºñŸ¹Î °áÇÌÁõº¸´Ùµµ ¿©·¯ Á¾·ùÀÇ ºñŸ¹Î °áÇÌÁõÀÌ ¸¹´Ù. ¼ÒÈ­±â Áúȯ¿¡ ¼ö¹ÝµÇ´Â Èí¼öÀå¾Ö, °¢Á¾ ¾àÀçÀÇ º¹¿ë¿¡ ÀÇÇÑ Àå³» ¼¼±ÕÃþÀÇ º¯È­, ü³»¿¡¼­ÀÇ ºñŸ¹Î Ȱ¼ºÈ­ÀÇ ÀúÇØ, »ý¸®Àû º¯È­¿¡ ´ëÀÀÇÑ ¿ä±¸·®ÀÇ Áõ°¡, °¨¿° µî¿¡ ÀÇÇØ °áÇÌÁõÀÌ ¹ß°ßµÇ´Â °æ¿ì°¡ ÀÖ´Ù. ±×·¯³ª ¾àÇÑ Á¤µµÀÇ °áÇÌÀÎ °æ¿ì¿¡´Â ÀüÇüÀû Áõ»óÀº º¸ÀÌÁö ¾ÊÀ¸¸ç, ÀÌ ¶§ÀÇ Áõ»óÀ» ºñŸ¹Î °¨¼ÒÁõÀ̶ó°í ÇÑ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
aspartic acid 2-oxoglutarate-dependent dioxygenase <enzyme> Hydroxylates one aspartic acid residue in the first egf-like unit of factor ix
Registry number: EC 1.14.11.-
Synonym: aspartate 2-oxoglutarate dioxygenase, asp-2-og-dioxygenase, aspartyl beta-hydroxylase, aspartyl (asparaginyl) beta-hydroxylase
(26 Jun 1999)
ATP dependent 26S protease <enzyme> Degrades proteins conjugated to ubiquitin; composed of cf-1,cf-2, and cf-3; cf-2 (also known as 240-kD proteasome inhibitor) is identical to aminolevulinic acid dehydratase
Registry number: EC 3.4.99.-
Synonym: 26s protease, 26 s proteasome complex, 26s proteasome
(26 Jun 1999)
ATP-dependent DNA strand transferase <enzyme> From human cell nuclei; catalyses strand exchange between homologous DNA sequences; magnesium dependent, requires ATP hydrolysis
Registry number: EC 2.7.7.-
Synonym: ATP-dep-DNA-str trnsfase
(26 Jun 1999)
ATP-ubiquitin-dependent proteinase <enzyme> A component of the cytosolic ubiquitin-dependent proteolysis system
Registry number: EC 3.4.-
Synonym: ucden
(26 Jun 1999)
autophosphorylation-dependent multifunctional protein kinase <enzyme> A camp/ca(2+)-independent protein kinase; phosphorylates and activates phosphorylase b kinase; phosphorylates and inactivates glycogen synthase
Registry number: EC 2.7.1.-
Synonym: auto-kinase
(26 Jun 1999)
calcium-calmodulin-dependent phosphodiesterase <enzyme> Hydrolyzes both cgmp and camp; induced during mitogenesis
Registry number: EC 3.1.4.-
Synonym: ca-cam-phosphodiesterase, calmodulin-dependent cgmp phosphodiesterase
(26 Jun 1999)
calcium-calmodulin dependent protein kinase <enzyme> A calmodulin-dependent enzyme that catalyses the phosphorylation of proteins. This enzyme is also sometimes dependent on calcium. A wide range of proteins can act as acceptor, including vimentin, synapsin, glycogen synthase, myosin light chains, and the microtubule-associated proteins.
Registry number: EC 2.7.10.-
(12 Dec 1998)
calcium-dependent protein kinase <enzyme> Mw 51,000; requires ca; not stimulated by calmodulin, phospholipids or diacylglycerol; phosphorylates casein and histones forming primarily phosphoserine and phosphothreonine, respectively
Registry number: EC 2.7.1.-
Synonym: paramecium ca-dependent protein kinase
(26 Jun 1999)
calcium dependent regulator protein <protein> (CDRP) Early name for calmodulin.
(18 Nov 1997)
calcium dependent sulfhydryl protease <enzyme> Hydrolyzes actin binding protein; enzyme from platelets
Registry number: EC 3.4.22.-
Synonym: cdsp
(26 Jun 1999)
calcium magnesium dependent endodeoxyribonuclease <enzyme> Similar in action but different from dnase i
Registry number: EC 3.1.21.-
Synonym: ca mg dnase, ca(2+)+mg(2+) dnase, calcium-magnesium endonuclease, ca-mg endonuclease
(26 Jun 1999)
calmodulin-dependent protein kinase IV kinase <enzyme> Phosphorylates and activates cam-kinase iv; from brain
Registry number: EC 2.7.10.-
Synonym: cam-kinase iv kinase
(26 Jun 1999)
palmitoyl-CoA dependent dehydrogenase <chemical> Sum of reactions catalyzed by fatty acyl-CoA oxidase, enoyl-CoA hydratase (EC 4.2.1.17) and beta-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.35)
Synonym: palmitoyl-coenzyme a dependent dehydrogenase
(26 Jun 1999)
RNA-dependent ATPase <enzyme> Requires single-stranded polynucleotide as cofactor
Registry number: EC 3.6.1.-
Synonym: atpase, RNA-dependent
(26 Jun 1999)
coenzyme F420-dependent alcohol dehydrogenase <enzyme> From methanogenium liminatans; catalyses oxidation of various secondary and cyclic alcohols to the corresponding ketones and the reverse reaction
Registry number: EC 1.1.99.-
Synonym: f(420) alcohol dehydrogenase
(26 Jun 1999)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á